Literature DB >> 21333553

Nuclear export of the NF-κB inhibitor IκBα is required for proper B cell and secondary lymphoid tissue formation.

Shelly M Wuerzberger-Davis1, Yuhong Chen, David T Yang, Jeffrey D Kearns, Paul W Bates, Candace Lynch, Nicholas C Ladell, Mei Yu, Andrew Podd, Hu Zeng, Tony T Huang, Renren Wen, Alexander Hoffmann, Demin Wang, Shigeki Miyamoto.   

Abstract

The N-terminal nuclear export sequence (NES) of inhibitor of nuclear factor kappa B (NF-κB) alpha (IκBα) promotes NF-κB export from the cell nucleus to the cytoplasm, but the physiological role of this export regulation remains unknown. Here we report the derivation and analysis of genetically targeted mice harboring a germline mutation in IκBα NES. Mature B cells in the mutant mice displayed nuclear accumulation of inactive IκBα complexes containing a NF-κB family member, cRel, causing their spatial separation from the cytoplasmic IκB kinase. This resulted in severe reductions in constitutive and canonical NF-κB activities, synthesis of p100 and RelB NF-κB members, noncanonical NF-κB activity, NF-κB target gene induction, and proliferation and survival responses in B cells. Consequently, mice displayed defective B cell maturation, antibody production, and formation of secondary lymphoid organs and tissues. Thus, IκBα nuclear export is essential to maintain constitutive, canonical, and noncanonical NF-κB activation potentials in mature B cells in vivo.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21333553      PMCID: PMC3111750          DOI: 10.1016/j.immuni.2011.01.014

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  52 in total

Review 1.  Missing pieces in the NF-kappaB puzzle.

Authors:  Sankar Ghosh; Michael Karin
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  IkappaBbeta, but not IkappaBalpha, functions as a classical cytoplasmic inhibitor of NF-kappaB dimers by masking both NF-kappaB nuclear localization sequences in resting cells.

Authors:  S Malek; Y Chen; T Huxford; G Ghosh
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

Review 3.  Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway.

Authors:  Falk Weih; Jorge Caamaño
Journal:  Immunol Rev       Date:  2003-10       Impact factor: 12.988

4.  Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.

Authors:  Shelby O'Connor; Stuart D Shumway; Ian J Amanna; Colleen E Hayes; Shigeki Miyamoto
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

5.  c-rel activates but v-rel suppresses transcription from kappa B sites.

Authors:  J Inoue; L D Kerr; L J Ransone; E Bengal; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

6.  Cell-specific association and shuttling of IkappaBalpha provides a mechanism for nuclear NF-kappaB in B lymphocytes.

Authors:  W F Tam; W Wang; R Sen
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

7.  The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells.

Authors:  Thomas Pohl; Raffi Gugasyan; Raelene J Grumont; Andreas Strasser; Donald Metcalf; David Tarlinton; William Sha; David Baltimore; Steve Gerondakis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

8.  Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin.

Authors:  P De Togni; J Goellner; N H Ruddle; P R Streeter; A Fick; S Mariathasan; S C Smith; R Carlson; L P Shornick; J Strauss-Schoenberger
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

9.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

10.  Combined deficiency of p50 and cRel in CD4+ T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function.

Authors:  Ye Zheng; Monika Vig; Jesse Lyons; Luk Van Parijs; Amer A Beg
Journal:  J Exp Med       Date:  2003-03-31       Impact factor: 14.307

View more
  18 in total

1.  DBC1 is a suppressor of B cell activation by negatively regulating alternative NF-κB transcriptional activity.

Authors:  Sinyi Kong; Muthusamy Thiruppathi; Quan Qiu; Zhenghong Lin; Hongxin Dong; Eduardo N Chini; Bellur S Prabhakar; Deyu Fang
Journal:  J Immunol       Date:  2014-10-31       Impact factor: 5.422

2.  Regulation and function of nuclear IκBα in inflammation and cancer.

Authors:  Ivana Vancurova; Ales Vancura
Journal:  Am J Clin Exp Immunol       Date:  2012-05-25

Review 3.  Double-edge Role of B Cells in Tumor Immunity: Potential Molecular Mechanism.

Authors:  Kai-Liang Zhao; Xiao-Jia Yang; Hong-Zhong Jin; Liang Zhao; Jian-Li Hu; Wen-Juan Qin
Journal:  Curr Med Sci       Date:  2019-10-14

4.  Demethoxycucumin protects MDA-MB-231 cells induced bone destruction through JNK and ERK pathways inhibition.

Authors:  Xiaofeng Shen; Xiaochen Sun; Hua Chen; Binjie Lu; Yuanyuan Qin; Chenxi Zhang; Guoqiang Liang; Jiangping Wang; Pengfei Yu; Li Su; Qihan Ma; Yuwei Li
Journal:  Cancer Chemother Pharmacol       Date:  2021-01-05       Impact factor: 3.333

5.  Chromatin-bound IκBα regulates a subset of polycomb target genes in differentiation and cancer.

Authors:  María Carmen Mulero; Dolors Ferres-Marco; Abul Islam; Pol Margalef; Matteo Pecoraro; Agustí Toll; Nils Drechsel; Cristina Charneco; Shelly Davis; Nicolás Bellora; Fernando Gallardo; Erika López-Arribillaga; Elena Asensio-Juan; Verónica Rodilla; Jessica González; Mar Iglesias; Vincent Shih; M Mar Albà; Luciano Di Croce; Alexander Hoffmann; Shigeki Miyamoto; Jordi Villà-Freixa; Nuria López-Bigas; William M Keyes; María Domínguez; Anna Bigas; Lluís Espinosa
Journal:  Cancer Cell       Date:  2013-07-11       Impact factor: 31.743

6.  c-Rel gain in B cells drives germinal center reactions and autoantibody production.

Authors:  Maike Kober-Hasslacher; Hyunju Oh-Strauß; Dilip Kumar; Valeria Soberon; Carina Diehl; Maciej Lech; Thomas Engleitner; Eslam Katab; Vanesa Fernández-Sáiz; Guido Piontek; Hongwei Li; Björn Menze; Christoph Ziegenhain; Wolfgang Enard; Roland Rad; Jan P Böttcher; Hans-Joachim Anders; Martina Rudelius; Marc Schmidt-Supprian
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

7.  XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.

Authors:  Jimi Kim; Elizabeth McMillan; Hyun Seok Kim; Niranjan Venkateswaran; Gurbani Makkar; Jaime Rodriguez-Canales; Pamela Villalobos; Jasper Edgar Neggers; Saurabh Mendiratta; Shuguang Wei; Yosef Landesman; William Senapedis; Erkan Baloglu; Chi-Wan B Chow; Robin E Frink; Boning Gao; Michael Roth; John D Minna; Dirk Daelemans; Ignacio I Wistuba; Bruce A Posner; Pier Paolo Scaglioni; Michael A White
Journal:  Nature       Date:  2016-09-28       Impact factor: 49.962

8.  Cyp1B1 expression promotes angiogenesis by suppressing NF-κB activity.

Authors:  Tammy L Palenski; Zafer Gurel; Christine M Sorenson; Kurt D Hankenson; Nader Sheibani
Journal:  Am J Physiol Cell Physiol       Date:  2013-10-02       Impact factor: 4.249

9.  IκBα deficiency imposes a fetal phenotype to intestinal stem cells.

Authors:  Laura Marruecos; Joan Bertran; Yolanda Guillén; Jéssica González; Raquel Batlle; Erika López-Arribillaga; Marta Garrido; Cristina Ruiz-Herguido; Dominique Lisiero; Mónica González-Farré; Sara Arce-Gallego; Mar Iglesias; Angel R Nebreda; Shigeki Miyamoto; Anna Bigas; Lluís Espinosa
Journal:  EMBO Rep       Date:  2020-04-09       Impact factor: 8.807

10.  IκBα Nuclear Export Enables 4-1BB-Induced cRel Activation and IL-2 Production to Promote CD8 T Cell Immunity.

Authors:  Dominique N Lisiero; Zhang Cheng; Melba M Tejera; Brandon T Neldner; Jay W Warrick; Shelly M Wuerzberger-Davis; Alexander Hoffmann; M Suresh; Shigeki Miyamoto
Journal:  J Immunol       Date:  2020-08-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.